PIK3CA and colonic neoplasm: Furthermore, there are two large ongoing placebo-controlled randomized controlled trials that examine the effect of both aspirin and metformin in stage I-III CRC, and the effect of aspirin in stage III and high-risk stage II colon cancer with PIK3CA mutation, respectively [13,14].